|
| 莱伯泰科(688056)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2023-09-04 | 4079.50 | 60.67% | 6723.64 | 0.00 | 2644.14 | 39.33% | 首发原股东限售股份 | | 2022-12-22 | 3.78 | 0.06% | 2644.14 | 4079.50 | 2644.14 | 39.33% | 股权激励一般股份 | | 2022-09-02 | 85.00 | 1.26% | 2640.36 | 4079.50 | 2640.36 | 39.29% | 首发战略配售股份 | | 2022-06-22 | 19.86 | 0.30% | 2555.36 | 4164.50 | 2555.36 | 38.03% | 股权激励一般股份 | | 2021-09-02 | 920.50 | 13.74% | 2535.50 | 4164.50 | 2535.50 | 37.84% | 首发原股东限售股份 |
|